Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 7,070,693
- Share change
- +327,250
- Total reported value
- $20,093,000
- Price per share
- $2.78
- Number of holders
- 13
- Value change
- +$878,266
- Number of buys
- 5
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$7,411,000 | — | 31 Mar 2016 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.8%
|
2,457,144
|
$7,187,000 | — | 31 Mar 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.54%
|
711,499
|
$2,082,000 | — | 31 Mar 2016 | |
| EverPoint Asset Management, LLC |
13F
|
Company |
0.45%
|
600,000
|
$1,746,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
145,200
|
$423,000 | — | 31 Mar 2016 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.07%
|
99,481
|
$292,000 | — | 31 Mar 2016 | |
| Abingworth LLP |
13F
|
Company |
0.07%
|
88,307
|
$256,000 | — | 31 Mar 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
30,400
|
$88,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
21,118
|
$61,000 | — | 31 Mar 2016 | |
| Redmile Group, LLC |
13F
|
Company |
0.01%
|
19,710
|
$58,000 | — | 31 Mar 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
10,823
|
$31,000 | — | 31 Mar 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
7,500
|
$22,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,099
|
$6,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,019
|
$6,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
300
|
$1,000 | — | 31 Mar 2016 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2016
As of 30 Jun 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,070,693 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, Abingworth LLP, Lombard Odier Asset Management (USA) Corp, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Redmile Group, LLC, and ROYAL BANK OF CANADA.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
16
Q2 2016 holders
13
Holder diff
-3
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.